M. Kolb (Hamilton, Canada), R. Chambers (London, United Kingdom)
VEGF gene transfer enhances fibrosis but improves pulmonary hemodynamics in experimental pulmonary fibrosis L. Farkas, K. Ask, A. Möller, D. Farkas, P. Margetts, J. Gauldie, M. Inman, M. Kolb (Hamilton, ON, Canada; Regensburg, Germany)
| |
Aminoguanidine attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of heat shock protein 47 and TGF-β1 expression L. Chen, F. Q. Wen, T. Wang, X. Wang, D. S. Liu (Chengdu, Sichuan, China)
| |
The PDE4 inhibitor roflumilast reduced bleomycin-induced pulmonary fibrotic and vascular remodeling in mice in vivo R. Benito, J. Cortijo, E. Donet, M. Mauricio, D. Ivars, E. Morcillo (Valencia, Spain)
| |
Carbon nanoparticles (CN) are a dramatic trigger in the process of bleomycin-induced pleural and subpleural fibrosis N. Decologne, G. Wettstein, C. Didelot, C. Garrido, P. Camus, P. Bonniaud (Dijon, France)
| |
Inhibition of napsin A induces proSP-B accumulation and ER-stress: a novel mouse model for lung fibrosis C. Ruppert, P. Mahavadi, T. Mokry, L. Schwertner, M. Korfei, I. Henneke, P. Markart, W. Seeger, A. Günther (Giessen, Germany)
| |
Anti-fibrotic effect of telmisartan on bleomycin-induced lung fibrosis in mice K. Miyamoto, S. Tasaka, H. Kamata, H. Seki, Y. Nakano, W. Yamasawa, N. Hasegawa, S. Fujishima, A. Ishizaka (Tokyo, Japan)
| |
Circulating fibrocytes in interstitial lung disease A. Fujiwara, H. Kobayashi, M. Masuya, A. Yamaguchi, T. Takagi, H. Nakahara, H. Fujimoto, T. Kobayashi, E. Gabazza, Y. Takei, O. Taguchi (Mie, Tsu City, Japan)
| |
Morphometric characteristic of pulmonary artery in COPD and idiopathic pulmonary fibrosis (IPF) L. M. Mikhaleva, A. L. Cherniayev, A. V. Bykanjva, M. V. Samsonova, T. G. Barkhina, G. V. Nekludova (Moscow, Russian Federation)
| |
Alveolar extracellular 20S proteasome in patients with acute respiratory distress syndrome S. Sixt, J. Hakenbeck, M. Adamzik, D. Spyrka, B. Saul, B. Dahlmann, J. Peters (Essen, Berlin, Germany)
| |
Role of TGF-b1 in type I collagen production in bronchial epithelial cells: effects on Smad7 inhibitory role? F. Magno, E. Jazrawi, P. Chou, G. La Rocca, B. Balbi, A. Di Stefano, I. Adcock (London, United Kingdom; Palermo, Veruno (NO), Italy)
| |
Time course of lung parenchyma remodelling in different models of extrapulmonary acute lung injury M. Chao, M. Oliveira, P. Silva, R. Santos, E. Parra, W. Teodoro, V. Capelozzi, P. Rocco (Rio de Janeiro, Sao Paulo, Brazil)
| |
Idiopathic interstitial pneumonia in relation to the gene polymorphisms of TNF-alpha and TNFR II N. Li, H. Dai, P. Xin, X. Li, L. V. Yueping, C. Wang (Beijing, China)
| |
Amifostine reduces lipopolysaccharide-induced lung dysfunction via suppression of redox-sensitive inflammatory signaling A. Birukova, F. Fu, K. Birukov (Chicago, IL, United States Of America)
| |
Efficacy of α-tocoferol in the treatment of patients with pneumonia U. Farkhutdinov (Ufa, Russian Federation)
| |
Characterization of small airways structural alterations in acute respiratory distress syndrome M. M. Morales, R. C. Pires-Neto, T. Lanças, L. F. F. Silva, N. Inforsato, T. Mauad, M. Dolhnikoff (São Paulo, Brazil)
| |
Processes of free radical oxidation in experimentally induced pneumonia U. Farkhutdinov (Ufa, Russian Federation)
| |
Evidence of type II pneumocyte apoptosis in the murine model of Hermansky-Pudlak-syndrome associated interstitial pneumonia P. Mahavadi, M. Korfei, I. Henneke, W. Seeger, A. Guenther, C. Ruppert (Giessen, Hessen, Germany)
| |
Pathological evaluation of the bleomycin induced lung injury in rats M. Kontogiorgi, I. Agrogiannis, G. Tsoukalas, A. Papalois, E. Patsouris (Athens, Greece)
| |
Capsaicin-sensitive nerves inactivation reduces lung parenchyma remodeling in guinea pigs with chronic allergic pulmonary inflammation C. Prado, G. da Rocha, E. Leick-Maldonado, C. Starling, V. Capelozzi, M. Martins, I. Tibério (São Paulo – SP, Brazil)
| |